Reuters logo
BRIEF-Lupin says U.S. FDA issues warning letter to co's Goa, Indore sites ‍​
November 7, 2017 / 7:43 AM / 17 days ago

BRIEF-Lupin says U.S. FDA issues warning letter to co's Goa, Indore sites ‍​

Nov 7 (Reuters) - Lupin Ltd

* Says U.S. FDA issues warning letter to co’s Goa and Indore sites

* Says likely delay of new product approvals from Goa, Pithampur facilities‍​‍​

* There will be no disruption of exisiting product supplies from either of these locations ‍​ Source text - bit.ly/2zC2nmS Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below